Cargando…

Prehabilitation in the lung cancer pathway: a scoping review

BACKGROUND: Lung cancer is the third most common type of cancer in the UK. Treatment outcomes are poor and UK deaths from lung cancer are higher than any other cancer. Prehabilitation has shown to be an important means of preparing patients both physically and psychologically for cancer treatment. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Wade-Mcbane, Kelly, King, Alex, Urch, Catherine, Jeyasingh-Jacob, Julian, Milne, Andrew, Boutillier, Clair Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416419/
https://www.ncbi.nlm.nih.gov/pubmed/37568130
http://dx.doi.org/10.1186/s12885-023-11254-x
_version_ 1785087771199668224
author Wade-Mcbane, Kelly
King, Alex
Urch, Catherine
Jeyasingh-Jacob, Julian
Milne, Andrew
Boutillier, Clair Le
author_facet Wade-Mcbane, Kelly
King, Alex
Urch, Catherine
Jeyasingh-Jacob, Julian
Milne, Andrew
Boutillier, Clair Le
author_sort Wade-Mcbane, Kelly
collection PubMed
description BACKGROUND: Lung cancer is the third most common type of cancer in the UK. Treatment outcomes are poor and UK deaths from lung cancer are higher than any other cancer. Prehabilitation has shown to be an important means of preparing patients both physically and psychologically for cancer treatment. However, little is understood about the context and mechanisms of prehabilitation that can impact physiological and psychological wellbeing. Our aim was to review and summarise primary research on prehabilitation in the lung cancer pathway using a realist approach. METHODS: A scoping review of empirical primary research was conducted. Five online medical databases from 2016 – February 2023 were searched. All articles reporting on prehabilitation in lung cancer were included in the review. For this review, prehabilitation was defined as either a uni-modal or multi-modal intervention including exercise, nutrition and/or psychosocial support within a home, community or hospital based setting. A realist framework of context, mechanism and outcome was used to assist with the interpretation of findings. RESULTS: In total, 31 studies were included in the review, of which, three were published study protocols. Over 95% of studies featured an exercise component as part of a prehabilitation programme. Twenty-six of the studies had a surgical focus. Only two studies reported using theory to underpin the design of this complex intervention. There was large heterogeneity across all studies as well as a lack of clinical trials to provide definitive evidence on the programme design, setting, type of intervention, patient criteria, delivery, duration and outcome measures used. CONCLUSION: A standardised prehabilitation programme for lung cancer patients does not yet exist. Future lung cancer prehabilitation programmes should take into account patient led values, needs, goals, support structures and beliefs, as these factors can affect the delivery and engagement of interventions. Future research should consider using a conceptual framework to conceptualise the living with and beyond cancer experience to help shape and inform personalised prehabilitation services.
format Online
Article
Text
id pubmed-10416419
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104164192023-08-12 Prehabilitation in the lung cancer pathway: a scoping review Wade-Mcbane, Kelly King, Alex Urch, Catherine Jeyasingh-Jacob, Julian Milne, Andrew Boutillier, Clair Le BMC Cancer Research BACKGROUND: Lung cancer is the third most common type of cancer in the UK. Treatment outcomes are poor and UK deaths from lung cancer are higher than any other cancer. Prehabilitation has shown to be an important means of preparing patients both physically and psychologically for cancer treatment. However, little is understood about the context and mechanisms of prehabilitation that can impact physiological and psychological wellbeing. Our aim was to review and summarise primary research on prehabilitation in the lung cancer pathway using a realist approach. METHODS: A scoping review of empirical primary research was conducted. Five online medical databases from 2016 – February 2023 were searched. All articles reporting on prehabilitation in lung cancer were included in the review. For this review, prehabilitation was defined as either a uni-modal or multi-modal intervention including exercise, nutrition and/or psychosocial support within a home, community or hospital based setting. A realist framework of context, mechanism and outcome was used to assist with the interpretation of findings. RESULTS: In total, 31 studies were included in the review, of which, three were published study protocols. Over 95% of studies featured an exercise component as part of a prehabilitation programme. Twenty-six of the studies had a surgical focus. Only two studies reported using theory to underpin the design of this complex intervention. There was large heterogeneity across all studies as well as a lack of clinical trials to provide definitive evidence on the programme design, setting, type of intervention, patient criteria, delivery, duration and outcome measures used. CONCLUSION: A standardised prehabilitation programme for lung cancer patients does not yet exist. Future lung cancer prehabilitation programmes should take into account patient led values, needs, goals, support structures and beliefs, as these factors can affect the delivery and engagement of interventions. Future research should consider using a conceptual framework to conceptualise the living with and beyond cancer experience to help shape and inform personalised prehabilitation services. BioMed Central 2023-08-11 /pmc/articles/PMC10416419/ /pubmed/37568130 http://dx.doi.org/10.1186/s12885-023-11254-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wade-Mcbane, Kelly
King, Alex
Urch, Catherine
Jeyasingh-Jacob, Julian
Milne, Andrew
Boutillier, Clair Le
Prehabilitation in the lung cancer pathway: a scoping review
title Prehabilitation in the lung cancer pathway: a scoping review
title_full Prehabilitation in the lung cancer pathway: a scoping review
title_fullStr Prehabilitation in the lung cancer pathway: a scoping review
title_full_unstemmed Prehabilitation in the lung cancer pathway: a scoping review
title_short Prehabilitation in the lung cancer pathway: a scoping review
title_sort prehabilitation in the lung cancer pathway: a scoping review
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416419/
https://www.ncbi.nlm.nih.gov/pubmed/37568130
http://dx.doi.org/10.1186/s12885-023-11254-x
work_keys_str_mv AT wademcbanekelly prehabilitationinthelungcancerpathwayascopingreview
AT kingalex prehabilitationinthelungcancerpathwayascopingreview
AT urchcatherine prehabilitationinthelungcancerpathwayascopingreview
AT jeyasinghjacobjulian prehabilitationinthelungcancerpathwayascopingreview
AT milneandrew prehabilitationinthelungcancerpathwayascopingreview
AT boutillierclairle prehabilitationinthelungcancerpathwayascopingreview